Systematic Modality Ablation of Multimodal Machine Learning for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease
Multimodal biomarkers have transformed Alzheimer's disease research, but the incremental contribution of individual modalities to predicting progression from mild cognitive impairment (MCI) remains unclear. We systematically evaluated the contribution of demographic, cognitive, genetic, structural imaging, cerebrospina...